Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Open Posted
- Opportunity number
- PAR-25-101
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $150,000
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- County Governments
- Higher Education Inst. (Public)
- Other
- Small Businesses
- Tribal Organizations (Not Federally Recognized)
- Independent School Districts
- Tribal Governments (Federally Recognized)
- State Governments
- Special District Governments
- City/Township Governments
- Public or Indian Housing Auth.
- 501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- For Profit Organizations
- Non-501(c)(3) Nonprofits
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institute on Drug Abuse is soliciting applications for Cutting-Edge Basic Research Awards (CEBRA), an R21 mechanism supporting high-risk, high-impact research on substance use disorders, with applications due August 11, 2027 under CFDA 93.279.
Eligible applicants include higher education institutions (public and private), state and local governments, tribal organizations (federally and non-federally recognized), nonprofits (501(c)(3) and non-501(c)(3)), small businesses, for-profit organizations, faith-based and community-based organizations, HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian serving institutions, AANAPISIs, TCCUs, eligible federal agencies, regional organizations, U.S. territories and possessions, and non-domestic entities.
CEBRA funds research that either develops or adapts revolutionary techniques or methods for addiction research with promising future applicability to substance use disorder research, or tests innovative and significant hypotheses with scant precedent or preliminary data that, if confirmed, would transform current understanding. The program specifically targets high-risk research that is sparse or absent from NIDA's current portfolio and has potential to transform the field.
No cost share requirement is stated. Award amounts, floor and ceiling, and expected number of awards are not specified in the available materials. Period of performance typically does not exceed five years under the parent Drug Use and Addiction Research Programs; place of performance is not restricted by applicant type or geography. Applications are reviewed for scientific and technical merit, feasibility, potential contribution to the national drug abuse problem, and relevance to NIDA priorities. The program follows standard NIH peer review and National Advisory Council procedures, with review timeframes of 240 to 270 days from submission.
Synopsis
2 versions
Update #2 · Latest ·
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Update #1 ·
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-101-Full-Announcement.html | HTML file | |
| PKG00289837.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity